ABEO
Abeona Therapeutics Inc
NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.37% today
Updated 2026-04-29
Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
—
52W range
$4 – $8
Volume
1.2M
Abeona Therapeutics Inc (ABEO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |